ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.737,36
-0,64%
S&P 500
4.967,23
-0,88%
Dow Jones
37.986,40
0,56%
Euro vs US Dollar
1,06705
0,00%
Bitcoin
63.720,01
-0,16%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Biogen Inc (BIIB)

  7. Biogen Inc (BIIB) News

BIIB Biogen Inc

194,38
3,86 (2,03%)
20 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Biogen Inc BIIB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
3,86 2,03% 194,38 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
190,72 189,44 194,525 194,38 190,52
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.4.202401:30PRNUSEisai Completes Submission of LEQEMBI® (lecanemab-irmb)..
06.3.202413:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
04.3.202422:15GLOBEBiogen Highlights New Data at the International Conference..
27.2.202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202413:00GLOBEBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
22.2.202416:12EDGAR2Form 144 - Report of proposed sale of securities
22.2.202403:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202403:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202403:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202403:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202416:24EDGAR2Form 144 - Report of proposed sale of securities
21.2.202403:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202413:07EDGAR2Form 8-K - Current report
13.2.202401:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202401:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202422:06GLOBEBiogen Received European Commission Approval for SKYCLARYS®..
12.2.202417:10EDGAR2Form 144 - Report of proposed sale of securities
10.2.202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.2.202402:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.2.202402:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.2.202402:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.2.202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.2.202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.2.202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.2.202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.2.202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.2.202401:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202416:44EDGAR2Form 144 - Report of proposed sale of securities
31.1.202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202420:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19.12.202313:30GLOBECentralized Marketing Authorizations of Generic Versions of..
15.12.202315:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
14.12.202312:30BWZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..

Kürzlich von Ihnen besucht

NASDAQ
BIIB
Biogen
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten